Suchergebnisse - "Jackson, Graham H"

PubPharm (164)

1

Genomic Classification and Individualized Prognosis in Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Maura, F. | Rajanna, A. | Ziccheddu, B. | +34

2

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

enthalten in: EClinicalMedicine | 2023

von Jones, J. | Cairns, D. | Menzies, T. | +15

3

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages : results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial

enthalten in: British journal of haematology | 2023

von Jenner, M. | Pawlyn, C. | Davies, F. | +16

4

Delayed diagnosis resulting in increased disease burden in multiple myeloma : the legacy of the COVID-19 pandemic

enthalten in: Blood cancer journal | 2023

von Carmichael, J. | Seymour, F. | McIlroy, G. | +9

5

Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia

enthalten in: JCI insight | 2023

von Stölzel, F. | Fordham, S. | Nandana, D. | +41

6

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages : results from ‘Myeloma XI’, a multicentre, open‐label, randomised, phase III trial

enthalten in: British Journal of Haematology | 2023

von Jenner, M. | Pawlyn, C. | Davies, F. | +15

7

Defining FiTNEss for treatment for multiple myeloma

enthalten in: The lancet. Healthy longevity | 2022

von Cook, G. | Pawlyn, C. | Cairns, D. | +1

CommentOn: BMJ Open. 2022 Jun 2;12(6):e056147. - PMID 35654466

8

Clinical characteristics and outcomes of IgD myeloma : experience across UK national trials

enthalten in: Blood advances | 2022

von Agbuduwe, C. | Iqbal, G. | Cairns, D. | +12

9

Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma : Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von de Tute, R. | Pawlyn, C. | Cairns, D. | +14

CommentIn: J Clin Oncol. 2022 Sep 1;40(25):2863-2866. - PMID 35772041

10

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

enthalten in: bioRxiv.org | 2022

von Lin, W. | Fordham, S. | Hungate, E. | +80

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]